Products focus on minimizing risk and maximizing outcomes
LIMERICK, Pa., Nov 30, 2010 (BUSINESS WIRE) --
Teleflex Incorporated will showcase a number of respiratory
products designed to help providers minimize risk and maximize outcomes
for their patientsat the annual AARC International Respiratory
Congress in Las Vegas, Nevada on December 6-9, 2010.
On display will be Teleflex's suite of ventilation management solutions
that are designed to promote best practices in Ventilator Associated
Pneumonia (VAP) risk reduction. VAP is the most common infection
acquired by adults and children in intensive care units (ICUs) and is a
cause of significant patient morbidity and mortality, increased
utilization of healthcare resources and excess cost.1 Recognizing
this challenge, Teleflex is committed to providing solutions that reduce
infection risk and ensure the reliable execution of evidence-based
medicine, including:
-
ISIS(R) HVT(TM) Endotracheal Tube: The ISIS HVT is the first
convertible endotracheal tube, allowing for subglottic secretion
removal, on demand. This versatile design eliminates the need to be
selective during initial intubation, increasing the number of patients
who can be viable candidates for subglottic secretion suctioning, a
clinically proven strategy for VAP reduction.1 In addition,
the ISIS HVT has been proven to reduce the incidence of suction lumen
clogging, a common challenge encountered by caregivers today.
-
Gibeck(R) Humid-Flo(R) Kit: An integrated system that promotes best
practices, the Gibeck Humid-Flo passive humidification kit allows all
components to remain in-line during the first 72 hours of mechanical
ventilation. This exclusive design allows for the consistent
application of VAP risk reduction strategies.1,2,3
-
ConchaTherm(R) Neptune(R): When combined with the ResMed NIV interface,
this heated humidifier works to promote patient compliance to Non
Invasive Positive Pressure Ventilation (NPPV), which has been
associated with higher survival rates and reduction of nosocomial
infections.4
Teleflex is also scheduled to participate in the RC Solutions Showcase
on Monday, December 6, during the congress. Jeri E Eiserman, BS, MBA,
RRT, Teleflex Director of Clinical Support will present a lecture
focused on respiratory solutions for reducing the risk of Ventilator
Associated Pneumonia. The focus of the discussion will be on products
and programs designed to help clinicians adhere to clinical practice
guidelines and recommendations from the CDC, IHI, AARC and SHEA.
"Teleflex, through our comprehensive portfolio of critical care
products, is dedicated to providing clinicians the tools to minimize
risk and maximize outcomes," said Cary Vance, Executive Vice President,
Teleflex, North America. "We are committed to working with the
respiratory community as a trusted resource and partner."
To see the ISIS HVT, the Gibeck Humid-Flo Passive Humidification Kit and
other Teleflex products, visit Teleflex at Booth 335 at AARC. For more
information on Teleflex's respiratory and airway management products,
visit www.teleflexmedical.com.
About Teleflex Incorporated
Teleflex Incorporated (NYSE: TFX) is a global provider of medical
technology products that enable healthcare providers to improve patient
outcomes, reduce infections and support patient and provider safety.
Teleflex, which employs approximately 12,800 people worldwide, also has
niche businesses that serve segments of the aerospace and commercial
markets with specialty engineered products. Additional information about
Teleflex can be obtained from the company's website at www.teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
1 Coffin S MD, MPH, Klompas M MD, Classen D MD, et al.
Strategies to Prevent Ventilator- Associated Pneumonia in Acute Care
Hospitals. Infect Control Hosp Epidemiol 2008; 29:S31-S40.
2 AARC
Evidence Based Guidelines, Care of the Ventilator Circuit and Its
Relation to Ventilator Associated Pneumonia. Respiratory Care
2003;48:875.
3 Guidelines for Preventing Hospital
Associated Pneumonia: Recommendations of CDC and the Healthcare
Infection Control Practices Advisory Committee 2003
4
Girou E, Schortgen F, Delclaux C, et al. Association of noninvasive
ventilation with nosocomial infections and survival in critically ill
patients. JAMA. 2000;284:2361-7.
SOURCE: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze, Vice President Investor Relations, 610-948-2836